Despite beating Wall Street expectations for revenue and profit, the tech giant missed on this key point. IBM announced ...

International Business Machines (NYSE: IBM) stock surged 14% higher following its fourth-quarter and 2024 earnings report. Under CEO Arvind Krishna, the company has redefined itself as primarily a ...

IBM is currently witnessing an uptrend in estimate revisions. Earnings estimates for 2025 have jumped 2% to $10.79 over the past year, while the same for 2026 has increased 5.5% to $11.61.

IBM is currently witnessing an uptrend in estimate revisions. Earnings estimates for 2025 have jumped 1.6% to $10.78 over the past 60 days, while the same for 2026 has increased 3.3% to $11.61.

International Business Machines Stock (NYSE: IBM)'s stock price has risen over 27% in the past year, reaching a near 52-week high of $243 per share as of early April 2025. The recent rally in IBM ...

Furthermore, the average IBM stock price target of $230.92 per share implies 3.65% upside potential from current levels. See more IBM analyst ratings. A Smart Way to Play Quantum .

The S&P 500 and the Nasdaq opened higher on Thursday as investors assessed tech earnings and monitored trade negotiations, ...

The average IBM stock price target is $143.20, implying 0.24% downside risk.The TakeawayWhile investors are more than free to jump aboard the hype train of other AI powerhouses, ...

Although the 40% rise in the stock price bodes well for IBM, its 41 P/E ratio may limit near-term growth without significant improvement. Funding the $150 billion. Moreover, ...

IBM is currently witnessing an uptrend in estimate revisions. Earnings estimates for 2025 have jumped 1.5% to $10.95 over the past 60 days, while the same for 2026 has increased 0.4% to $11.66.

At $145.00, the average IBM stock price target suggests 10.7% upside potential.The TakeawayWith its hefty 5% dividend yield, IBM is likely to lure prospective investors, ...

With artificial intelligence (AI) representing the hot ticket in the broader technology ecosystem, it’s tempting to chase the flavor of the week. However, patient investors may want to consider ...